Page 2 - Distributed Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biotechnology Company Centivax Officially Launches News provided by Share this article Share this article SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Centivax Inc. is proud to announce its launch on Jan. 1, 2021, as a fully independent biotechnology company developing broad-spectrum therapeutics and a vaccines portfolio, including indications in COVID-19, multi-drug resistant bacteria, influenza, antivenom and oncology. "Our unusually mature portfolio of fully owned Centivax assets has been made possible by advanced computational immunoengineering technology platforms and intellectual p...

Charles River Acquires Cell and Gene Therapy CDMO Cognate for $875M Charles River Laboratories plans to acquire the cell and gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices for approximately $875 million cash, in a deal that further expands the buyer’s activity in the fast-growing sector. [Cognate BioServices] February 18, 2021 Charles River Laboratories plans to acquire the cell and gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices for approximately $875 million cash, in a deal that further expands the b...

Charles River Laboratories International Inc (CRL) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Charles River Laboratories International Inc (NYSE: CRL) Popular Searches Operator Ladies and gentlemen, thank you for standing by and welcome to Charles River Laboratories International Fourth Quarter Earnings Conference Call and 2021 guidance call. At this time, all participants are in a listen-only mode [Operator Instructions] Please be advised, today's conference is being recorded. [Operator Instructions]...